Reduction of cardiac hypertrophy in TGR(mREN2)27 by angiotensin II receptor blockade

被引：0
|
作者：
Bohm, M
Lippoldt, A
Wienen, W
Ganten, D
Bader, M
机构：
[1] MAX DELBRUCK CTR MOL MED, D-13125 BERLIN, GERMANY
[2] DR KARL THOMAE GMBH, PHARMA RES A, D-7950 BIBERACH, GERMANY
来源：
MOLECULAR AND CELLULAR BIOCHEMISTRY | 1996年 / 164卷
关键词：
heart hypertrophy; transgenic rats; hypertension; angiotensin II;
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
TGR(mREN2)27 is a transgenic rat harboring the murine Ren-2 gene and exhibit fulminant hypertension and marked heart hypertrophy. In order to study the role of angiotensin II in the increase of cardiac mass, these animals were treated with antihypertensive and non-antihypertensive doses of the angiotensin II receptor AT(1) antagonist Telmisartan for 9 weeks. All doses led to significant reductions of heart hypertrophy detected by the evaluation of the diameter of cardiac muscle bundles, We conclude from this study that cardiac hypertrophy in TGR(mREN2)27 is characterized by an increased volume of cardiomyocytes and an unchanged amount of fibrous tissue and that angiotensin II plays an important role in the mechanisms leading to this phenotype.
引用
收藏
页码：217 / 221
页数：5
相关论文
共 50 条
  • [41] ROLE OF TISSUE RENIN IN THE PATHOPHYSIOLOGY OF HYPERTENSION IN TGR(MREN2)27 RATS
    BADER, M
    ZHAO, Y
    SANDER, M
    LEE, MA
    BACHMANN, J
    BOHM, M
    DJAVIDANI, B
    PETERS, J
    MULLINS, JJ
    GANTEN, D
    HYPERTENSION, 1992, 19 (06) : 681 - 686
  • [42] Calcineurin independent development of myocardial hypertrophy in transgenic rats overexpressing the mouse renin gene, TGR(mREN2)27
    Diedrichs, H
    Mei, C
    Frank, KF
    Boelck, B
    Schwinger, RHG
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2004, 82 (10): : 688 - 695
  • [43] Calcineurin independent development of myocardial hypertrophy in transgenic rats overexpressing the mouse renin gene, TGR(mREN2)27
    H. Diedrichs
    C. Mei
    K. F. Frank
    B. Boelck
    R. H. G. Schwinger
    Journal of Molecular Medicine, 2004, 82 : 688 - 695
  • [44] Specific MAP-kinase blockade protects against renal damage in homozygous TGR(mRen2)27 rats
    de Borst, MH
    Navis, G
    de Boer, RA
    Huitema, S
    Vis, LM
    van Gilst, WH
    van Goor, H
    LABORATORY INVESTIGATION, 2003, 83 (12) : 1761 - 1770
  • [45] Spironolactone enhances the beneficial effect of aliskiren on cardiac structural and electrical remodeling in TGR(mRen2)27 rats
    De Mello, Walmor C.
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2015, 16 (03) : 488 - 494
  • [46] THE ANGIOTENSIN-II ANTAGONIST BIBR277 NORMALIZES BLOOD-PRESSURE AND IMPROVES KIDNEY DAMAGE IN TGR(MREN2)27
    BOHM, M
    LEE, M
    KREUTZ, R
    KIM, S
    SCHINKE, M
    WAGNER, J
    KALING, M
    WIENEN, W
    BADER, M
    GANTEN, D
    FASEB JOURNAL, 1993, 7 (03): : A246 - A246
  • [47] Angiotensin peptides acting at the rostral ventrolateral medulla contribute to the hypertension of TGR(mREN2)27 transgenic rats.
    Fontes, MAP
    Baltatu, O
    Bader, M
    Ganten, D
    Campagnole-Santos, MJ
    Santos, RAS
    HYPERTENSION, 1998, 32 (03) : 594 - 594
  • [48] Signal transduction in cardiac and vascular tissue from normotensive and transgenic hypertensive TGR(mREN2)27 rats
    Witte, K
    Schnecko, A
    Perbandt, K
    Höfer, S
    Lemmer, B
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 341 (2-3) : 337 - 341
  • [49] ENHANCED ALDOSTERONE BIOSYNTHESIS IN TGR(MREN2)27 - FUNCTIONAL-SIGNIFICANCE OF AN INTRAADRENAL RENIN-ANGIOTENSIN SYSTEM
    PETERS, J
    DJAVIDANI, B
    MUNTER, K
    BADER, M
    SANDER, M
    MULLINS, J
    GANTEN, D
    NIEREN-UND HOCHDRUCKKRANKHEITEN, 1992, 21 (11) : 545 - 546
  • [50] Normalisation of blood pressure in hypertensive TGR(mREN2)27 rats by amlodipine vs. enalapril: effects on cardiac hypertrophy and signal transduction pathways
    Witte, K
    Huser, L
    Knotter, B
    Heckmann, M
    Schiffer, S
    Lemmer, B
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2001, 363 (01) : 101 - 109
12345